Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6975381 | 1.00 | SRC (0.77) | SRCKDR | |
| SCHEMBL3192521 | 0.90 | SRC (0.95) | SRCKDR | |
| SCHEMBL3282493 | 0.88 | SRC (1.00) | SRCKDR | |
| SCHEMBL3281905 | 0.85 | SRC (1.00) | SRCKDR | |
| SCHEMBL3276140 | 0.84 | SRC (0.86) | SRCKDR | |
| SCHEMBL3283205 | 0.83 | SRC (0.84) | SRCKDR | |
| SCHEMBL3200998 | 0.82 | SRC (1.00) | SRCKDR | |
| SCHEMBL3740944 | 0.81 | SRC (0.83) | SRCKDR | |
| SCHEMBL3196301 | 0.80 | SRC (1.00) | SRCKDR | |
| SCHEMBL3195124 | 0.78 | SRC (1.00) | SRCKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001094341-A9 | QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMOURS | ASTRAZENECA AB (SE) | 2003-04-17 | — | — | WO | disclosed |
| EP-1292594-A1 | QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMOURS | AstraZeneca AB (SE) | 2003-03-19 | — | — | EP | disclosed |
| WO-2001094341-A1 | QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMOURS | ASTRAZENECA AB (SE) | 2001-12-13 | — | — | WO | disclosed |